LAKE FOREST, Ill.--(BUSINESS WIRE)--Oct. 16, 2017--
IDEX Corporation (NYSE: IEX) today announced its financial results
for the three month period ended September 30, 2017.
Third Quarter 2017 Highlights
-
Orders were up 8 percent overall and 7 percent organically
-
Sales were up 8 percent overall and 7 percent organically
-
Operating margin was 22.0 percent
-
EPS was $1.08, up 17 cents, or 19 percent
Third Quarter 2017
Orders of $573.8 million were up 8 percent (+7 percent organic and +1
percent foreign currency translation) compared with the prior year
period.
Sales of $574.5 million were up 8 percent (+7 percent organic and +1
percent foreign currency translation) compared with the prior year
period.
Gross margin of 44.9 percent was up 140 basis points from the prior year
period. Excluding $4.6 million of pre-tax fair value inventory step-up
charges from the prior year period, gross margin would have been up 50
basis points primarily due to volume leverage.
Operating income of $126.5 million resulted in an operating margin of
22.0 percent, up 130 basis points from the prior year operating margin
and 90 basis points from the prior year adjusted operating margin.
Excluding the $4.6 million fair value step-up charges from the prior
year results, operating margin would have been up 10 basis points.
Operating income drove EBITDA of $146.1 million which was 25 percent of
sales and covered interest expense by more than 13 times.
Net income was $83.8 million which resulted in EPS of $1.08, up 17
cents, or 19 percent, from the prior year period. Excluding the net loss
on divestitures from the prior year period, EPS was up 16 cents, or 17
percent from adjusted prior year EPS.
Cash from operations for the third quarter of $124.0 million led to free
cash flow of $115.5 million, which converted at 138 percent of net
income.
The Company repurchased 116 thousand shares of common stock for $13.8
million in the third quarter of 2017.
|
|
|
“Solid execution, coupled with increasing demand, delivered another
strong quarter for IDEX. Third quarter organic orders and sales both
grew 7 percent, which drove operating margin of 22.0 percent. HST
and FMT continued to lead the way with 10 percent and 7 percent
organic revenue growth, respectively. This growth resulted in EPS of
$1.08 which was up 16 cents, or 17 percent, from the adjusted prior
year period. Free cash flow was very strong with a conversion rate
at 138 percent of net income.
|
|
|
|
I am pleased with the solid organic growth rates we have achieved
this year. Consistent with our capital deployment strategy, our
number one priority is to fully fund long-term organic growth
opportunities. Our commitment to segmenting our businesses and
funding our best organic initiatives is helping to deliver on our
goal of outperforming our underlying markets. Looking ahead, we will
continue to fund these opportunities as an integral part of our
capital deployment objectives which include pursuing strategic M&A,
funding our dividend and being opportunistic in repurchasing our
shares.
|
|
|
|
Based on our third quarter results and strength in orders across all
three segments, we are raising full year 2017 adjusted EPS guidance
to $4.25 to $4.27, with fourth quarter EPS of $1.06 to $1.08. We
also reaffirm full year 2017 organic revenue growth of 5 percent,
with 6 percent organic growth expected in the fourth quarter.”
|
|
|
|
Andrew K. Silvernail
|
|
Chairman and Chief Executive Officer
|
|
|
Third Quarter 2017 Segment Highlights
Fluid & Metering Technologies
-
Sales of $221.0 million reflected a 6 percent increase compared to the
third quarter of 2016 (+7 percent organic, -2 percent divestitures and
+1 percent foreign currency translation).
-
Operating income of $62.0 million resulted in an operating margin of
28.1 percent, a 130 basis point increase compared to the prior year
period operating margin primarily due to higher volume, cost savings
from prior year restructuring initiatives and lower amortization.
-
EBITDA of $68.0 million resulted in an EBITDA margin of 30.8 percent,
a 60 basis point increase compared to the prior year period EBITDA
margin.
Health & Science Technologies
-
Sales of $207.1 million reflected a 13 percent increase compared to
the third quarter of 2016 (+10 percent organic and +3 percent
acquisition/divestitures).
-
Operating income of $46.1 million resulted in an operating margin of
22.2 percent, a 190 basis point increase compared to the prior year
period operating margin primarily due to higher volume and the
inclusion of a fair value inventory step-up charge in the prior year
period.
-
EBITDA of $58.2 million resulted in an EBITDA margin of 28.1 percent,
a 150 basis point increase compared to the prior year period EBITDA
margin.
Fire & Safety/Diversified Products
-
Sales of $146.6 million reflected a 6 percent increase compared to the
third quarter of 2016 (+4 percent organic and +2 percent foreign
currency translation).
-
Operating income of $36.2 million resulted in an operating margin of
24.7 percent, a 130 basis point increase compared to the prior year
period operating margin primarily due to higher volume and the
inclusion of a fair value inventory step-up charge in the prior year
period.
-
EBITDA of $38.9 million resulted in an EBITDA margin of 26.5 percent,
a 40 basis point increase compared to the prior year period EBITDA
margin.
For the third quarter of 2017, Fluid & Metering Technologies
contributed 38 percent of sales, 43 percent of operating income and 41
percent of EBITDA; Health & Science Technologies accounted for 36
percent of sales, 32 percent of operating income and 35 percent of
EBITDA; and Fire & Safety/Diversified Products represented 26 percent of
sales, 25 percent of operating income and 24 percent of EBITDA.
Non-U.S. GAAP Measures of Financial Performance
The Company supplements certain U.S. GAAP financial performance metrics
with non-U.S. GAAP financial performance metrics in order to provide
investors with better insight and increased transparency while also
allowing for a more comprehensive understanding of the financial
information used by management in its decision making. Reconciliations
of non-U.S. GAAP financial performance metrics to their most comparable
U.S. GAAP financial performance metrics are defined and presented below
and should not be considered a substitute for, nor superior to, the
financial data prepared in accordance with U.S. GAAP. There were no
adjustments to U.S. GAAP financial performance metrics other than the
items noted below.
-
Organic orders and sales are calculated according to U.S. GAAP
excluding amounts from acquired or divested businesses during the
first twelve months of ownership or divestiture and the impact of
foreign currency translation.
-
Adjusted operating income is calculated as operating income plus
restructuring expenses plus or minus the net loss or gain on sale of
businesses.
-
Adjusted operating margin is calculated as adjusted operating income
divided by net sales.
-
Adjusted net income is calculated as net income plus restructuring
expenses plus or minus the net loss or gain on sale of businesses, net
of the statutory tax expense or benefit.
-
EBITDA is calculated as net income plus interest expense plus
provision for income taxes plus depreciation and amortization. We
reconciled EBITDA to net income on a consolidated basis as we do not
allocate consolidated interest expense or consolidated provision for
income taxes to our segments.
-
Adjusted EBITDA is calculated as EBITDA plus restructuring expenses
plus or minus the net loss or gain on sale of businesses.
-
Free cash flow is calculated as cash flow from operating activities
less capital expenditures.
|
|
|
Table 1: Reconciliations of the Change in Net Sales to Net
Organic Sales
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30, 2017
|
|
|
September 30, 2017
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
IDEX
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
IDEX
|
|
Change in net sales
|
|
|
6%
|
|
13%
|
|
6%
|
|
8%
|
|
|
3%
|
|
10%
|
|
12%
|
|
8%
|
|
- Net impact from acquisitions/divestitures
|
|
|
(2%)
|
|
3%
|
|
0%
|
|
0%
|
|
|
(2%)
|
|
4%
|
|
12%
|
|
4%
|
|
- Impact from FX
|
|
|
1%
|
|
0%
|
|
2%
|
|
1%
|
|
|
0%
|
|
(1%)
|
|
(1%)
|
|
(1%)
|
|
Change in net organic sales
|
|
|
7%
|
|
10%
|
|
4%
|
|
7%
|
|
|
5%
|
|
7%
|
|
1%
|
|
5%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 2: Reconciliations of Reported-to-Adjusted Operating
Income and Margin (dollars in thousands)
|
|
|
|
|
|
|
Quarter Ended September 30,
|
|
|
|
|
2017
|
|
|
|
2016 (e)
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
IDEX
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
Reported operating income (loss)
|
|
|
$
|
61,988
|
|
|
$
|
46,073
|
|
|
$
|
36,199
|
|
|
$
|
(17,756
|
)
|
|
$
|
126,504
|
|
|
|
$
|
55,907
|
|
|
$
|
37,195
|
|
|
$
|
32,492
|
|
|
$
|
(15,886
|
)
|
|
$
|
109,708
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,067
|
|
|
|
2,067
|
|
|
Adjusted operating income (loss)
|
|
|
$
|
61,988
|
|
|
$
|
46,073
|
|
|
$
|
36,199
|
|
|
$
|
(17,756
|
)
|
|
$
|
126,504
|
|
|
|
$
|
55,907
|
|
|
$
|
37,195
|
|
|
$
|
32,492
|
|
|
$
|
(13,819
|
)
|
|
$
|
111,775
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales (eliminations)
|
|
|
$
|
220,953
|
|
|
$
|
207,127
|
|
|
$
|
146,599
|
|
|
$
|
(189
|
)
|
|
$
|
574,490
|
|
|
|
$
|
208,335
|
|
|
$
|
183,564
|
|
|
$
|
138,767
|
|
|
$
|
(310
|
)
|
|
$
|
530,356
|
|
|
Operating margin
|
|
|
|
28.1
|
%
|
|
|
22.2
|
%
|
|
|
24.7
|
%
|
|
|
n/m
|
|
|
|
22.0
|
%
|
|
|
|
26.8
|
%
|
|
|
20.3
|
%
|
|
|
23.4
|
%
|
|
|
n/m
|
|
|
|
20.7
|
%
|
|
Adjusted operating margin
|
|
|
|
28.1
|
%
|
|
|
22.2
|
%
|
|
|
24.7
|
%
|
|
|
n/m
|
|
|
|
22.0
|
%
|
|
|
|
26.8
|
%
|
|
|
20.3
|
%
|
|
|
23.4
|
%
|
|
|
n/m
|
|
|
|
21.1
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2017
|
|
|
|
2016 (e)
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
IDEX
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
Reported operating income (loss)
|
|
|
$
|
179,830
|
|
|
$
|
134,605
|
|
|
$
|
106,022
|
|
|
$
|
(53,149
|
)
|
|
$
|
367,308
|
|
|
|
$
|
161,782
|
|
|
$
|
118,985
|
|
|
$
|
92,566
|
|
|
$
|
(46,457
|
)
|
|
$
|
326,876
|
|
|
+Restructuring expenses
|
|
|
|
1,566
|
|
|
|
3,028
|
|
|
|
73
|
|
|
|
130
|
|
|
|
4,797
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,067
|
|
|
|
2,067
|
|
|
Adjusted operating income (loss)
|
|
|
$
|
181,396
|
|
|
$
|
137,633
|
|
|
$
|
106,095
|
|
|
$
|
(53,019
|
)
|
|
$
|
372,105
|
|
|
|
$
|
161,782
|
|
|
$
|
118,985
|
|
|
$
|
92,566
|
|
|
$
|
(44,390
|
)
|
|
$
|
328,943
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales (eliminations)
|
|
|
$
|
658,905
|
|
|
$
|
611,215
|
|
|
$
|
432,029
|
|
|
$
|
(741
|
)
|
|
$
|
1,701,408
|
|
|
|
$
|
641,988
|
|
|
$
|
556,475
|
|
|
$
|
384,996
|
|
|
$
|
(835
|
)
|
|
$
|
1,582,624
|
|
|
Operating margin
|
|
|
|
27.3
|
%
|
|
|
22.0
|
%
|
|
|
24.5
|
%
|
|
|
n/m
|
|
|
|
21.6
|
%
|
|
|
|
25.2
|
%
|
|
|
21.4
|
%
|
|
|
24.0
|
%
|
|
|
n/m
|
|
|
|
20.7
|
%
|
|
Adjusted operating margin
|
|
|
|
27.5
|
%
|
|
|
22.5
|
%
|
|
|
24.6
|
%
|
|
|
n/m
|
|
|
|
21.9
|
%
|
|
|
|
25.2
|
%
|
|
|
21.4
|
%
|
|
|
24.0
|
%
|
|
|
n/m
|
|
|
|
20.8
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 3: Reconciliations of Reported-to-Adjusted Net Income
and EPS (in thousands, except EPS)
|
|
|
|
|
|
|
Quarter
|
|
|
Nine Months
|
|
|
|
|
Ended September 30,
|
|
|
Ended September 30,
|
|
|
|
|
2017
|
|
2016
|
|
|
2017
|
|
2016
|
|
Reported net income
|
|
|
$
|
83,768
|
|
$
|
69,873
|
|
|
|
$
|
243,511
|
|
|
$
|
213,762
|
|
|
+Restructuring expenses
|
|
|
|
-
|
|
|
-
|
|
|
|
|
4,797
|
|
|
|
-
|
|
|
+Tax impact on restructuring expenses
|
|
|
|
-
|
|
|
-
|
|
|
|
|
(1,529
|
)
|
|
|
-
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
2,067
|
|
|
|
|
-
|
|
|
|
2,067
|
|
|
+Tax impact on loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
(1,467
|
)
|
|
|
|
-
|
|
|
|
(1,467
|
)
|
|
Adjusted net income
|
|
|
$
|
83,768
|
|
$
|
70,473
|
|
|
|
$
|
246,779
|
|
|
$
|
214,362
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reported EPS
|
|
|
$
|
1.08
|
|
$
|
0.91
|
|
|
|
$
|
3.15
|
|
|
$
|
2.78
|
|
|
+Restructuring expenses
|
|
|
|
-
|
|
|
-
|
|
|
|
|
0.06
|
|
|
|
-
|
|
|
+Tax impact on restructuring expenses
|
|
|
|
-
|
|
|
-
|
|
|
|
|
(0.02
|
)
|
|
|
-
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
0.03
|
|
|
|
|
-
|
|
|
|
0.03
|
|
|
+Tax impact on loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
(0.02
|
)
|
|
|
|
-
|
|
|
|
(0.02
|
)
|
|
Adjusted EPS
|
|
|
$
|
1.08
|
|
$
|
0.92
|
|
|
|
$
|
3.19
|
|
|
$
|
2.79
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares
|
|
|
|
77,523
|
|
|
76,880
|
|
|
|
|
77,246
|
|
|
|
76,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 4: Reconciliations of EBITDA to Net Income (dollars
in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended September 30,
|
|
|
|
|
2017
|
|
2016 (e)
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
Operating income (loss)
|
|
|
$
|
61,988
|
|
|
$
|
46,073
|
|
|
$
|
36,199
|
|
|
$
|
(17,756
|
)
|
|
$
|
126,504
|
|
|
$
|
55,907
|
|
|
$
|
37,195
|
|
|
$
|
32,492
|
|
|
$
|
(15,886
|
)
|
|
$
|
109,708
|
|
|
- Other (income) expense - net
|
|
|
|
230
|
|
|
|
(970
|
)
|
|
|
1,044
|
|
|
|
1,349
|
|
|
|
1,653
|
|
|
|
171
|
|
|
|
(384
|
)
|
|
|
(195
|
)
|
|
|
(1,105
|
)
|
|
|
(1,513
|
)
|
|
+ Depreciation and amortization
|
|
|
|
6,192
|
|
|
|
11,189
|
|
|
|
3,709
|
|
|
|
190
|
|
|
|
21,280
|
|
|
|
7,168
|
|
|
|
11,163
|
|
|
|
3,584
|
|
|
|
277
|
|
|
|
22,192
|
|
|
EBITDA
|
|
|
|
67,950
|
|
|
|
58,232
|
|
|
|
38,864
|
|
|
|
(18,915
|
)
|
|
|
146,131
|
|
|
|
62,904
|
|
|
|
48,742
|
|
|
|
36,271
|
|
|
|
(14,504
|
)
|
|
|
133,413
|
|
|
- Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
11,064
|
|
|
|
|
|
|
|
|
|
|
|
11,913
|
|
|
- Provision for income taxes
|
|
|
|
|
|
|
|
|
|
|
|
30,019
|
|
|
|
|
|
|
|
|
|
|
|
29,435
|
|
|
- Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
21,280
|
|
|
|
|
|
|
|
|
|
|
|
22,192
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
$
|
83,768
|
|
|
|
|
|
|
|
|
|
|
$
|
69,873
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales (eliminations)
|
|
|
$
|
220,953
|
|
|
$
|
207,127
|
|
|
$
|
146,599
|
|
|
$
|
(189
|
)
|
|
$
|
574,490
|
|
|
$
|
208,335
|
|
|
$
|
183,564
|
|
|
$
|
138,767
|
|
|
$
|
(310
|
)
|
|
$
|
530,356
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin
|
|
|
|
28.1
|
%
|
|
|
22.2
|
%
|
|
|
24.7
|
%
|
|
|
n/m
|
|
|
|
22.0
|
%
|
|
|
26.8
|
%
|
|
|
20.3
|
%
|
|
|
23.4
|
%
|
|
|
n/m
|
|
|
|
20.7
|
%
|
|
EBITDA margin
|
|
|
|
30.8
|
%
|
|
|
28.1
|
%
|
|
|
26.5
|
%
|
|
|
n/m
|
|
|
|
25.4
|
%
|
|
|
30.2
|
%
|
|
|
26.6
|
%
|
|
|
26.1
|
%
|
|
|
n/m
|
|
|
|
25.2
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2017
|
|
2016 (e)
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
Operating income (loss)
|
|
|
$
|
179,830
|
|
|
$
|
134,605
|
|
|
$
|
106,022
|
|
|
$
|
(53,149
|
)
|
|
$
|
367,308
|
|
|
$
|
161,782
|
|
|
$
|
118,985
|
|
|
$
|
92,566
|
|
|
$
|
(46,457
|
)
|
|
$
|
326,876
|
|
|
- Other (income) expense - net
|
|
|
|
707
|
|
|
|
97
|
|
|
|
1,663
|
|
|
|
(750
|
)
|
|
|
1,717
|
|
|
|
566
|
|
|
|
(1,548
|
)
|
|
|
(485
|
)
|
|
|
(1,029
|
)
|
|
|
(2,496
|
)
|
|
+ Depreciation and amortization
|
|
|
|
17,823
|
|
|
|
34,447
|
|
|
|
10,938
|
|
|
|
598
|
|
|
|
63,806
|
|
|
|
22,011
|
|
|
|
33,044
|
|
|
|
8,316
|
|
|
|
953
|
|
|
|
64,324
|
|
|
EBITDA
|
|
|
|
196,946
|
|
|
|
168,955
|
|
|
|
115,297
|
|
|
|
(51,801
|
)
|
|
|
429,397
|
|
|
|
183,227
|
|
|
|
153,577
|
|
|
|
101,367
|
|
|
|
(44,475
|
)
|
|
|
393,696
|
|
|
- Interest expense
|
|
|
|
|
|
|
|
|
|
|
|
33,920
|
|
|
|
|
|
|
|
|
|
|
|
33,607
|
|
|
- Provision for income taxes
|
|
|
|
|
|
|
|
|
|
|
|
88,160
|
|
|
|
|
|
|
|
|
|
|
|
82,003
|
|
|
- Depreciation and amortization
|
|
|
|
|
|
|
|
|
|
|
|
63,806
|
|
|
|
|
|
|
|
|
|
|
|
64,324
|
|
|
Net income
|
|
|
|
|
|
|
|
|
|
|
$
|
243,511
|
|
|
|
|
|
|
|
|
|
|
$
|
213,762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales (eliminations)
|
|
|
$
|
658,905
|
|
|
$
|
611,215
|
|
|
$
|
432,029
|
|
|
$
|
(741
|
)
|
|
$
|
1,701,408
|
|
|
$
|
641,988
|
|
|
$
|
556,475
|
|
|
$
|
384,996
|
|
|
$
|
(835
|
)
|
|
$
|
1,582,624
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating margin
|
|
|
|
27.3
|
%
|
|
|
22.0
|
%
|
|
|
24.5
|
%
|
|
|
n/m
|
|
|
|
21.6
|
%
|
|
|
25.2
|
%
|
|
|
21.4
|
%
|
|
|
24.0
|
%
|
|
|
n/m
|
|
|
|
20.7
|
%
|
|
EBITDA margin
|
|
|
|
29.9
|
%
|
|
|
27.6
|
%
|
|
|
26.7
|
%
|
|
|
n/m
|
|
|
|
25.2
|
%
|
|
|
28.5
|
%
|
|
|
27.6
|
%
|
|
|
26.3
|
%
|
|
|
n/m
|
|
|
|
24.9
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 5: Reconciliations of EBITDA to Adjusted EBITDA
(dollars in thousands)
|
|
|
|
|
|
|
Quarter Ended September 30,
|
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
EBITDA
|
|
|
$
|
67,950
|
|
|
$
|
58,232
|
|
|
$
|
38,864
|
|
|
$
|
(18,915
|
)
|
|
$
|
146,131
|
|
|
|
$
|
62,904
|
|
|
$
|
48,742
|
|
|
$
|
36,271
|
|
|
$
|
(14,504
|
)
|
|
$
|
133,413
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,067
|
|
|
|
2,067
|
|
|
Adjusted EBITDA
|
|
|
$
|
67,950
|
|
|
$
|
58,232
|
|
|
$
|
38,864
|
|
|
$
|
(18,915
|
)
|
|
$
|
146,131
|
|
|
|
$
|
62,904
|
|
|
$
|
48,742
|
|
|
$
|
36,271
|
|
|
$
|
(12,437
|
)
|
|
$
|
135,480
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margin
|
|
|
|
30.8
|
%
|
|
|
28.1
|
%
|
|
|
26.5
|
%
|
|
|
n/m
|
|
|
|
25.4
|
%
|
|
|
|
30.2
|
%
|
|
|
26.6
|
%
|
|
|
26.1
|
%
|
|
|
n/m
|
|
|
|
25.5
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
|
FMT
|
|
HST
|
|
FSDP
|
|
Corporate
|
|
IDEX
|
|
EBITDA
|
|
|
$
|
196,946
|
|
|
$
|
168,955
|
|
|
$
|
115,297
|
|
|
$
|
(51,801
|
)
|
|
$
|
429,397
|
|
|
|
$
|
183,227
|
|
|
$
|
153,577
|
|
|
$
|
101,367
|
|
|
$
|
(44,475
|
)
|
|
$
|
393,696
|
|
|
+Restructuring expenses
|
|
|
|
1,566
|
|
|
|
3,028
|
|
|
|
73
|
|
|
|
130
|
|
|
|
4,797
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
+Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,067
|
|
|
|
2,067
|
|
|
Adjusted EBITDA
|
|
|
$
|
198,512
|
|
|
$
|
171,983
|
|
|
$
|
115,370
|
|
|
$
|
(51,671
|
)
|
|
$
|
434,194
|
|
|
|
$
|
183,227
|
|
|
$
|
153,577
|
|
|
$
|
101,367
|
|
|
$
|
(42,408
|
)
|
|
$
|
395,763
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Adjusted EBITDA margin
|
|
|
|
30.1
|
%
|
|
|
28.1
|
%
|
|
|
26.7
|
%
|
|
|
n/m
|
|
|
|
25.5
|
%
|
|
|
|
28.5
|
%
|
|
|
27.6
|
%
|
|
|
26.3
|
%
|
|
|
n/m
|
|
|
|
25.0
|
%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Table 6: Reconciliations of Free Cash Flow (in
thousands)
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
|
June 30,
|
|
|
September 30,
|
|
|
|
|
2017
|
|
2016
|
|
|
2017
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash flow from operating activities
|
|
|
$
|
124,000
|
|
$
|
125,480
|
|
|
$
|
87,601
|
|
|
$
|
296,580
|
|
$
|
284,324
|
|
- Capital expenditures
|
|
|
|
8,515
|
|
|
11,590
|
|
|
|
9,377
|
|
|
|
28,054
|
|
|
28,642
|
|
Free cash flow
|
|
|
$
|
115,485
|
|
$
|
113,890
|
|
|
$
|
78,224
|
|
|
$
|
268,526
|
|
$
|
255,682
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Conference Call to be Broadcast over the
Internet
IDEX will broadcast its third quarter earnings conference call over the
Internet on Tuesday, October 17, 2017 at 9:30 a.m. CT. Chairman and
Chief Executive Officer Andy Silvernail and Senior Vice President and
Chief Financial Officer William Grogan will discuss the Company’s recent
financial performance and respond to questions from the financial
analyst community. IDEX invites interested investors to listen to the
call and view the accompanying slide presentation, which will be carried
live on its website at www.idexcorp.com.
Those who wish to participate should log on several minutes before the
discussion begins. After clicking on the presentation icon, investors
should follow the instructions to ensure their systems are set up to
hear the event and view the presentation slides, or download the correct
applications at no charge. Investors will also be able to hear a replay
of the call by dialing 877.660.6853 (or 201.612.7415 for international
participants) using the ID #13652255.
Forward-Looking Statements
This news release contains “forward-looking” statements within the
meaning of the Private Securities Litigation Reform Act of 1995, as
amended. These statements may relate to, among other things, capital
expenditures, acquisitions, cost reductions, cash flow, revenues,
earnings, market conditions, global economies and operating
improvements, and are indicated by words or phrases such as
“anticipates,” “estimates,” “plans,” “expects,” “projects,” “forecasts,”
“should,” “could,” “will,” “management believes,” “the Company
believes,” “the Company intends,” and similar words or phrases. These
statements are subject to inherent uncertainties and risks that could
cause actual results to differ materially from those anticipated at the
date of this news release. The risks and uncertainties include, but are
not limited to, the following: economic and political consequences
resulting from terrorist attacks and wars; levels of industrial activity
and economic conditions in the U.S. and other countries around the
world; pricing pressures and other competitive factors, and levels of
capital spending in certain industries – all of which could have a
material impact on order rates and IDEX’s results, particularly in light
of the low levels of order backlogs it typically maintains; its ability
to make acquisitions and to integrate and operate acquired businesses on
a profitable basis; the relationship of the U.S. dollar to other
currencies and its impact on pricing and cost competitiveness; political
and economic conditions in foreign countries in which the company
operates; interest rates; capacity utilization and the effect this has
on costs; labor markets; market conditions and material costs; and
developments with respect to contingencies, such as litigation and
environmental matters. Additional factors that could cause actual
results to differ materially from those reflected in the forward-looking
statements include, but are not limited to, the risks discussed in the
“Risk Factors” section included in the Company’s most recent annual
report on Form 10-K filed with the SEC and the other risks discussed in
the Company’s filings with the SEC. The forward-looking statements
included here are only made as of the date of this news release, and
management undertakes no obligation to publicly update them to reflect
subsequent events or circumstances, except as may be required by law.
Investors are cautioned not to rely unduly on forward-looking statements
when evaluating the information presented here.
About IDEX
IDEX Corporation is an applied solutions company specializing in fluid
and metering technologies, health and science technologies, and fire,
safety and other diversified products built to its customers’ exacting
specifications. Its products are sold in niche markets to a wide range
of industries throughout the world. IDEX shares are traded on the New
York Stock Exchange and Chicago Stock Exchange under the symbol “IEX”.
For further information on IDEX Corporation and its business units,
visit the company’s website at www.idexcorp.com.
(Financial reports follow)
|
|
|
|
|
|
|
|
|
|
|
|
IDEX CORPORATION
|
|
Condensed Consolidated Statements of Operations
|
|
(in thousands except per share amounts)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
Nine Months Ended
|
|
|
|
|
September 30,
|
|
September 30,
|
|
|
|
|
2017
|
|
2016 (e)
|
|
2017
|
|
2016 (e)
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
574,490
|
|
$
|
530,356
|
|
|
$
|
1,701,408
|
|
$
|
1,582,624
|
|
|
Cost of sales
|
|
|
|
316,560
|
|
|
299,467
|
|
|
|
935,612
|
|
|
884,342
|
|
|
Gross profit
|
|
|
|
257,930
|
|
|
230,889
|
|
|
|
765,796
|
|
|
698,282
|
|
|
Selling, general and administrative expenses
|
|
|
|
131,426
|
|
|
119,114
|
|
|
|
393,691
|
|
|
369,339
|
|
|
Restructuring expenses
|
|
|
|
-
|
|
|
-
|
|
|
|
4,797
|
|
|
-
|
|
|
Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
2,067
|
|
|
|
-
|
|
|
2,067
|
|
|
Operating income
|
|
|
|
126,504
|
|
|
109,708
|
|
|
|
367,308
|
|
|
326,876
|
|
|
Other (income) expense - net
|
|
|
|
1,653
|
|
|
(1,513
|
)
|
|
|
1,717
|
|
|
(2,496
|
)
|
|
Interest expense
|
|
|
|
11,064
|
|
|
11,913
|
|
|
|
33,920
|
|
|
33,607
|
|
|
Income before income taxes
|
|
|
|
113,787
|
|
|
99,308
|
|
|
|
331,671
|
|
|
295,765
|
|
|
Provision for income taxes
|
|
|
|
30,019
|
|
|
29,435
|
|
|
|
88,160
|
|
|
82,003
|
|
|
Net income
|
|
|
$
|
83,768
|
|
$
|
69,873
|
|
|
$
|
243,511
|
|
$
|
213,762
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Earnings per Common Share (a):
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per common share
|
|
|
$
|
1.09
|
|
$
|
0.92
|
|
|
$
|
3.19
|
|
$
|
2.81
|
|
|
Diluted earnings per common share
|
|
|
$
|
1.08
|
|
$
|
0.91
|
|
|
$
|
3.15
|
|
$
|
2.78
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Share Data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average common shares outstanding
|
|
|
|
76,309
|
|
|
75,819
|
|
|
|
76,215
|
|
|
75,753
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average common shares outstanding
|
|
|
|
77,523
|
|
|
76,880
|
|
|
|
77,246
|
|
|
76,742
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidated Balance Sheets
|
|
(in thousands)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
September 30,
|
|
December 31,
|
|
|
|
|
|
|
|
|
2017
|
|
2016
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
Current assets
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
|
|
|
|
|
$
|
303,291
|
|
$
|
235,964
|
|
|
Receivables - net
|
|
|
|
|
|
|
|
307,505
|
|
|
272,813
|
|
|
Inventories
|
|
|
|
|
|
|
|
266,705
|
|
|
252,859
|
|
|
Other current assets
|
|
|
|
|
|
|
|
77,977
|
|
|
61,085
|
|
|
Total current assets
|
|
|
|
|
|
|
|
955,478
|
|
|
822,721
|
|
|
Property, plant and equipment - net
|
|
|
|
|
|
|
|
250,889
|
|
|
247,816
|
|
|
Goodwill and intangible assets
|
|
|
|
|
|
|
|
2,094,621
|
|
|
2,068,096
|
|
|
Other noncurrent assets
|
|
|
|
|
|
|
|
16,773
|
|
|
16,311
|
|
|
Total assets
|
|
|
|
|
|
|
$
|
3,317,761
|
|
$
|
3,154,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities and shareholders' equity
|
|
|
|
|
|
|
|
|
|
|
Current liabilities
|
|
|
|
|
|
|
|
|
|
|
Trade accounts payable
|
|
|
|
|
|
|
$
|
137,917
|
|
$
|
128,933
|
|
|
Accrued expenses
|
|
|
|
|
|
|
|
170,223
|
|
|
152,852
|
|
|
Short-term borrowings
|
|
|
|
|
|
|
|
347
|
|
|
1,046
|
|
|
Dividends payable
|
|
|
|
|
|
|
|
28,364
|
|
|
26,327
|
|
|
Total current liabilities
|
|
|
|
|
|
|
|
336,851
|
|
|
309,158
|
|
|
Long-term borrowings
|
|
|
|
|
|
|
|
874,853
|
|
|
1,014,235
|
|
|
Other noncurrent liabilities
|
|
|
|
|
|
|
|
295,745
|
|
|
287,657
|
|
|
Total liabilities
|
|
|
|
|
|
|
|
1,507,449
|
|
|
1,611,050
|
|
|
Shareholders' equity
|
|
|
|
|
|
|
|
1,810,312
|
|
|
1,543,894
|
|
|
Total liabilities and shareholders' equity
|
|
|
|
|
|
|
$
|
3,317,761
|
|
$
|
3,154,944
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IDEX CORPORATION
|
|
Condensed Consolidated Statements of Cash Flows
|
|
(in thousands)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30,
|
|
|
|
|
2017
|
|
|
2016
|
|
|
|
|
|
|
|
|
|
Cash flows from operating activities
|
|
|
|
|
|
|
|
Net income
|
|
|
$
|
243,511
|
|
|
|
$
|
213,762
|
|
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
|
|
|
|
|
|
|
Loss (gain) on sale of businesses - net
|
|
|
|
-
|
|
|
|
|
2,067
|
|
|
Depreciation and amortization
|
|
|
|
28,425
|
|
|
|
|
28,360
|
|
|
Amortization of intangible assets
|
|
|
|
35,381
|
|
|
|
|
35,964
|
|
|
Amortization of debt issuance costs
|
|
|
|
989
|
|
|
|
|
1,150
|
|
|
Share-based compensation expense
|
|
|
|
18,143
|
|
|
|
|
15,325
|
|
|
Deferred income taxes
|
|
|
|
1,888
|
|
|
|
|
4,880
|
|
|
Non-cash interest expense associated with forward starting swaps
|
|
|
|
5,004
|
|
|
|
|
5,144
|
|
|
Changes in (net of the effect from acquisitions and divestitures):
|
|
|
|
|
|
|
|
Receivables
|
|
|
|
(28,407
|
)
|
|
|
|
(2,178
|
)
|
|
Inventories
|
|
|
|
(4,869
|
)
|
|
|
|
22,250
|
|
|
Other current assets
|
|
|
|
(15,113
|
)
|
|
|
|
(18,276
|
)
|
|
Trade accounts payable
|
|
|
|
3,681
|
|
|
|
|
(16,696
|
)
|
|
Accrued expenses
|
|
|
|
9,912
|
|
|
|
|
(2,982
|
)
|
|
Other — net
|
|
|
|
(1,965
|
)
|
|
|
|
(4,446
|
)
|
|
Net cash flows provided by operating activities
|
|
|
|
296,580
|
|
|
|
|
284,324
|
|
|
Cash flows from investing activities
|
|
|
|
|
|
|
|
Purchases of property, plant and equipment
|
|
|
|
(28,054
|
)
|
|
|
|
(28,642
|
)
|
|
Acquisition of businesses, net of cash acquired
|
|
|
|
-
|
|
|
|
|
(510,001
|
)
|
|
Proceeds from sale of businesses, net of cash sold
|
|
|
|
-
|
|
|
|
|
32,529
|
|
|
Proceeds from fixed asset disposals
|
|
|
|
5,159
|
|
|
|
|
-
|
|
|
Other — net
|
|
|
|
(337
|
)
|
|
|
|
(73
|
)
|
|
Net cash flows used in investing activities
|
|
|
|
(23,232
|
)
|
|
|
|
(506,187
|
)
|
|
Cash flows from financing activities
|
|
|
|
|
|
|
|
Borrowings under revolving facilities
|
|
|
|
33,000
|
|
|
|
|
460,524
|
|
|
Proceeds from 3.20% Senior Notes
|
|
|
|
-
|
|
|
|
|
100,000
|
|
|
Proceeds from 3.37% Senior Notes
|
|
|
|
-
|
|
|
|
|
100,000
|
|
|
Payments under revolving facilities
|
|
|
|
(181,692
|
)
|
|
|
|
(402,172
|
)
|
|
Debt issuance costs
|
|
|
|
-
|
|
|
|
|
(246
|
)
|
|
Dividends paid
|
|
|
|
(82,869
|
)
|
|
|
|
(77,367
|
)
|
|
Proceeds from stock option exercises
|
|
|
|
18,980
|
|
|
|
|
23,154
|
|
|
Purchase of common stock
|
|
|
|
(22,650
|
)
|
|
|
|
(57,272
|
)
|
|
Unvested shares surrendered for tax withholding
|
|
|
|
(5,903
|
)
|
|
|
|
(4,899
|
)
|
|
Settlement of foreign exchange contracts
|
|
|
|
4,406
|
|
|
|
|
-
|
|
|
Net cash flows provided by (used in) financing activities
|
|
|
|
(236,728
|
)
|
|
|
|
141,722
|
|
|
Effect of exchange rate changes on cash and cash equivalents
|
|
|
|
30,707
|
|
|
|
|
(8,480
|
)
|
|
Net increase (decrease)
|
|
|
|
67,327
|
|
|
|
|
(88,621
|
)
|
|
Cash and cash equivalents at beginning of year
|
|
|
|
235,964
|
|
|
|
|
328,018
|
|
|
Cash and cash equivalents at end of period
|
|
|
$
|
303,291
|
|
|
|
$
|
239,397
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
IDEX CORPORATION
|
|
Company and Segment Financial Information - Reported
|
|
(dollars in thousands)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended
|
|
|
Nine Months Ended
|
|
|
|
|
|
|
September 30, (b)
|
|
|
September 30, (b)
|
|
|
|
|
|
|
2017
|
|
|
2016 (e)
|
|
|
2017
|
|
|
2016 (e)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fluid & Metering Technologies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
220,953
|
|
|
|
$
|
208,335
|
|
|
|
$
|
658,905
|
|
|
|
$
|
641,988
|
|
|
|
|
Operating income (c)
|
|
|
|
61,988
|
|
|
|
|
55,907
|
|
|
|
|
179,830
|
|
|
|
|
161,782
|
|
|
|
|
Operating margin
|
|
|
|
28.1
|
|
%
|
|
|
26.8
|
|
%
|
|
|
27.3
|
|
%
|
|
|
25.2
|
|
%
|
|
|
EBITDA
|
|
|
$
|
67,950
|
|
|
|
$
|
62,904
|
|
|
|
$
|
196,946
|
|
|
|
$
|
183,227
|
|
|
|
|
EBITDA margin
|
|
|
|
30.8
|
|
%
|
|
|
30.2
|
|
%
|
|
|
29.9
|
|
%
|
|
|
28.5
|
|
%
|
|
|
Depreciation and amortization
|
|
|
$
|
6,192
|
|
|
|
$
|
7,168
|
|
|
|
$
|
17,823
|
|
|
|
$
|
22,011
|
|
|
|
|
Capital expenditures
|
|
|
|
3,944
|
|
|
|
|
5,091
|
|
|
|
|
12,159
|
|
|
|
|
12,704
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Health & Science Technologies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
207,127
|
|
|
|
$
|
183,564
|
|
|
|
$
|
611,215
|
|
|
|
$
|
556,475
|
|
|
|
|
Operating income (c)
|
|
|
|
46,073
|
|
|
|
|
37,195
|
|
|
|
|
134,605
|
|
|
|
|
118,985
|
|
|
|
|
Operating margin
|
|
|
|
22.2
|
|
%
|
|
|
20.3
|
|
%
|
|
|
22.0
|
|
%
|
|
|
21.4
|
|
%
|
|
|
EBITDA
|
|
|
$
|
58,232
|
|
|
|
$
|
48,742
|
|
|
|
$
|
168,955
|
|
|
|
$
|
153,577
|
|
|
|
|
EBITDA margin
|
|
|
|
28.1
|
|
%
|
|
|
26.6
|
|
%
|
|
|
27.6
|
|
%
|
|
|
27.6
|
|
%
|
|
|
Depreciation and amortization
|
|
|
$
|
11,189
|
|
|
|
$
|
11,163
|
|
|
|
$
|
34,447
|
|
|
|
$
|
33,044
|
|
|
|
|
Capital expenditures
|
|
|
|
3,015
|
|
|
|
|
4,450
|
|
|
|
|
11,489
|
|
|
|
|
11,455
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fire & Safety/Diversified Products
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
146,599
|
|
|
|
$
|
138,767
|
|
|
|
$
|
432,029
|
|
|
|
$
|
384,996
|
|
|
|
|
Operating income (c)
|
|
|
|
36,199
|
|
|
|
|
32,492
|
|
|
|
|
106,022
|
|
|
|
|
92,566
|
|
|
|
|
Operating margin
|
|
|
|
24.7
|
|
%
|
|
|
23.4
|
|
%
|
|
|
24.5
|
|
%
|
|
|
24.0
|
|
%
|
|
|
EBITDA
|
|
|
$
|
38,864
|
|
|
|
$
|
36,271
|
|
|
|
$
|
115,297
|
|
|
|
$
|
101,367
|
|
|
|
|
EBITDA margin
|
|
|
|
26.5
|
|
%
|
|
|
26.1
|
|
%
|
|
|
26.7
|
|
%
|
|
|
26.3
|
|
%
|
|
|
Depreciation and amortization
|
|
|
$
|
3,709
|
|
|
|
$
|
3,584
|
|
|
|
$
|
10,938
|
|
|
|
$
|
8,316
|
|
|
|
|
Capital expenditures
|
|
|
|
1,506
|
|
|
|
|
2,034
|
|
|
|
|
4,178
|
|
|
|
|
4,305
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate Office and Eliminations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Intersegment sales eliminations
|
|
|
$
|
(189
|
)
|
|
|
$
|
(310
|
)
|
|
|
$
|
(741
|
)
|
|
|
$
|
(835
|
)
|
|
|
|
Operating loss (c)
|
|
|
|
(17,756
|
)
|
|
|
|
(15,886
|
)
|
|
|
|
(53,149
|
)
|
|
|
|
(46,457
|
)
|
|
|
|
EBITDA
|
|
|
|
(18,915
|
)
|
|
|
|
(14,504
|
)
|
|
|
|
(51,801
|
)
|
|
|
|
(44,475
|
)
|
|
|
|
Depreciation and amortization
|
|
|
|
190
|
|
|
|
|
277
|
|
|
|
|
598
|
|
|
|
|
953
|
|
|
|
|
Capital expenditures
|
|
|
|
50
|
|
|
|
|
15
|
|
|
|
|
228
|
|
|
|
|
178
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Company
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
|
$
|
574,490
|
|
|
|
$
|
530,356
|
|
|
|
$
|
1,701,408
|
|
|
|
$
|
1,582,624
|
|
|
|
|
Operating income
|
|
|
|
126,504
|
|
|
|
|
109,708
|
|
|
|
|
367,308
|
|
|
|
|
326,876
|
|
|
|
|
Operating margin
|
|
|
|
22.0
|
|
%
|
|
|
20.7
|
|
%
|
|
|
21.6
|
|
%
|
|
|
20.7
|
|
%
|
|
|
EBITDA
|
|
|
$
|
146,131
|
|
|
|
$
|
133,413
|
|
|
|
$
|
429,397
|
|
|
|
$
|
393,696
|
|
|
|
|
EBITDA margin
|
|
|
|
25.4
|
|
%
|
|
|
25.2
|
|
%
|
|
|
25.2
|
|
%
|
|
|
24.9
|
|
%
|
|
|
Depreciation and amortization (d)
|
|
|
$
|
21,280
|
|
|
|
$
|
22,192
|
|
|
|
$
|
63,806
|
|
|
|
$
|
64,324
|
|
|
|
|
Capital expenditures
|
|
|
|
8,515
|
|
|
|
|
11,590
|
|
|
|
|
28,054
|
|
|
|
|
28,642
|
|
|
|
(a)
|
|
Calculated by applying the two-class method of allocating
earnings to common stock and participating securities as required by
ASC 260, Earnings Per Share.
|
|
|
|
|
|
|
|
(b)
|
|
Three and nine month data includes the results of SFC Koenig
(September 2016) in the Health & Science Technologies segment and
Akron Brass (March 2016) and AWG Fittings (July 2016) in the Fire &
Safety/Diversified Products segment from the date of acquisition.
Three and nine month data also includes the results of Hydra-Stop
(July 2016) and IETG (October 2016) in the Fluid & Metering
Technologies segment and CVI Japan (September 2016) and CVI Korea
(December 2016) in the Health & Science Technologies segment through
the date of disposition.
|
|
|
|
|
|
|
|
(c)
|
|
Segment operating income excludes unallocated corporate operating
expenses which are included in Corporate Office and Eliminations.
|
|
|
|
|
|
|
|
(d)
|
|
Depreciation and amortization excludes amortization of debt
issuance costs.
|
|
|
|
|
|
|
|
(e)
|
|
Certain amounts in the prior year presentation have been
reclassified to conform to the current presentation due to the early
adoption of ASU 2017-07, Compensation-Retirement Benefits (Topic
715): Improving the Presentation of Net Periodic Pension Cost and
Net Periodic Postretirement Benefit Cost.
|
|
|
|
|
|
|

View source version on businesswire.com: http://www.businesswire.com/news/home/20171016006255/en/
Source: IDEX Corporation
IDEX Corporation
Investor Contact:
William K.
Grogan
Senior Vice President and Chief Financial Officer
(847)
498-7070